REAL-WORLD EFFECTIVENESS OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED FOR UPTO 2YEARS IN CLINICAL PRACTICE: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH
sponsorship: We thank the physicians and patients who participated in these studies. The study was funded by Alfasigma S.p.A. (Bologna, Italy) . Medical writing support was provided by Debbie Sherwood, BSc, CMPP (Aspire Scientific, Bollington, UK) , and funded by Alfasigma S.p.A. Publication coordination was provided by Steve Winter, PhD, and funded by Alfasigma S.p.A. (Alfasigma S.p.A. (Bologna, Italy), Alfasigma S.p.A)
Publication Details
- Journal
- Lirias (KU Leuven)
- Published
- 2025-06-01
- DOI
- https://doi.org/10.1136/annrheumdis-2025-eular.b2475
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00